TRANSPLANT home | Faculty listing

UT Transplant Center Faculty

Charles R. Nolan, III, MD

Professor of Medicine and Surgery
Medical Director, Kidney and Pancreas Transplantation, University Hospital Transplant Center

Photo Email: nolan@uthscsa.edu

Board Certifications:
American Board of Internal Medicine, Nephrology
American Board of Internal Medicine, Internal Medicine

Education:
MD, 1980, University of Colorado School of Medicine, Denver, CO

Postgraduate training:
1985, Clinical Fellowship, Nephrology Fellowship, University of Colorado School of Medicine, Denver, CO
1983, Clinical Fellowship, Internal Medicine Residency, Wilford Hall Medical Center, Lackland AFB , TX

Research interests: renal dialysis, renal transplantation, herpes viral infection and immune responses in organ transplants.

Clinical interests: kidney and pancreas transplantation

Publications:
Qunibi WY, Abouzahr F, Mizani MR, Nolan CR, Arya R, Hunt KJ. Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes Kidney Int 2005 Jan;68:271-277.

Qunibi WY, Hootkins RE, McDowell L, Meyer MS, Simon M, Garza R, Pelham R, Cleveland M VB, Nolan C. Treatment of Hyperphosphatemia in Hemodialysis Patients: The Calcium Acetate Renagel Evaluation (CARE Study) Kidney International 2004 May;65:1914-1926.

Abstract: Nolan CR, Velez LE. Attainment of NKF K/DOQI guidelines among patients referred for renal transplantation; 2005 Jan. (J Am Soc Nephrol; vol. 16).

Review Article: Nolan CR. Strategies for improving long-term survival in patients with ESRD J Am Soc Nephrol 2005 Nov;16 Su:120-127.

Nolan CR. Phosphate binder therapy for attainment of K/DOQI bone metabolism guidelines Kidney Int Suppl 2005 Jul;(96):7-14.

Nolan CR, Qunibi WY. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis Kidney Int Suppl 2005 Jun;(95):13-20.

Brezina B, Qunibi WY, Nolan CR. Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications Kidney Int Suppl 2004 Sep;(90):39-45.

Qunibi WY, Nolan CR. Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study Kidney Int Suppl 2004 Sep;(90):33-38.

Other: Qunibi WY, Nolan CR. Economic impact of sevelamer in patients with ESRD Kidney Int 2005 Apr;67(4):1636-1637.

Biosketch: Dr. Nolan is the Medical Director of the kidney and pancreas transplant program at University Hospital. He received his undergraduate and medical degrees from the University of Colorado. He completed his Internal Medicine residency training at Wilford Hall Medical Center, Lackland Air Force Base, Texas. He completed his fellowship in Nephrology at the University of Colorado in Denver. Dr. Nolan served as the chief of the Nephrology division at Wilford Hall Medical Center before joining the faculty at The UT Health Science Center in 1992. Dr. Nolan is responsible for the evaluation of patients who are candidates for kidney and pancreas transplant. He also manages the long-term care of kidney and pancreas transplant patients. Dr. Nolan has an active research laboratory involved in studying mechanisms of kidney transplant rejection with research grant funding from the Veterans Administration. Dr. Nolan is the principal investigator for numerous clinical research studies in the areas of kidney transplant, renal dialysis and hypertension (high blood pressure).

Awards and honors:
2010, San Antonio Magazine 'Best Doctors'

Professional Societies: